Endothelin-1 (ET-1) is a potent vasoconstrictor peptide plasma renin activity (PRA) and the ET-1 levels of hypertensives; instead there was a statistically significant derived from endothelial cells and may be important in the control of systemic blood pressure (BP) and local correlation between plasma ET-1 and plasma aldosterone (PA) (r = 0.393; P Ͻ 0.026). In particular mean blood flow. Immunoreactive ET-1 plasma levels may be normal or elevated in human arterial hypertension, plasma ET-1 values in patients with low-renin essential hypertension (12.6 ± 2.1 pg/ml) were significantly higher although the exact pathophysiological role of ET-1 remains to be established.
Introduction
in vivo in humans has been provided by a report Endothelin-1 (ET-1) has potent vasopressor effects 1, 2 describing two patients affected by malignant hemand may therefore play a part in the regulation of angioendothelioma and hypertension. 10 Surgical blood pressure (BP) and in the pathogenesis of excision of the tumours led to a reduction in plasma hypertension. An association between elevated cir-ET-1 levels and resolution of hypertension, and in culating ET-1 levels and essential hypertension has one patient recurrence of the tumour was associated been noted in several [3] [4] [5] but not in all studies. 6, 7 In with an increase of plasma ET-1 and BP levels. our previous study 8 we did not detect a difference in Although the exact pathophysiological role of ET-1 plasma ET-1 levels between borderline hypertensive remains to be established. and normotensive control subjects. However, in the With regard to renin-angiotensin-aldosterone sysborderline hypertensive group ET-1 levels increased tem studies, using pharmacological doses of ET-1 in during standard cold pressor test. It is unclear vivo have demonstrated a significant increase in whether this association is indicative of a causal role plasma aldosterone (PA); 11, 12 in contrast in vitro for ET-1 in the pathogenesis of essential hypertenstudies reported an inhibitory action of endothelin sion, or whether it simply reflects the fact that the on renin release from juxtaglomerular cells 13, 14 and shear stress exerted by elevated BP on endothelial a stimulation of aldosterone biosynthesis from adrecells lining the vasculature can stimulate the nal cells. 15, 16 secretion. 9 The aim of the study was to determine the relationship between plasma renin activity (PRA), PA and plasma ET-1 levels in individuals with low, 8%, respectively. Ambulatory subjects with mild essential hyper-ET-1 was measured by RIA as we have previously tension were recruited between 1992 and 1995 from described. 22 In short, ET-1 was extracted from the I Medical Pathology Division of the University samples with C18 column (Sep Column) after acidiof Rome. The patients were 40, recruited as part of fication with 1 ml of 0.1% thrifluoroacetic acid and an ongoing study in which hypertensive factors 2 NHCL (pH = 3), and eluted with 60% acetonitrile. were evaluated.
The extracts were evaporated under nitrogen and An initial evaluation of each patient included the then assayed with a specific RIA (RIC-6901, Penindetermination of the plasma renin/urinary sodium sula Laboratories, Belmont, CA, USA). Cross-reacprofile. Renin/sodium profiles were developed tivity with ET-2 and ET-3 was 7%. Cross-reactivity according to the procedure described by Laragh et with human big endothelin was 17%. All assays al. [17] [18] [19] were performed in duplicate and ET-1 concenUsing this technique we enrolled:
trations expressed as pg/ml. (1) thirteen patients with low-renin hypertension (10 men and 3 women; mean age 43.5 ± 16.2
Statistical analysis years);
All data are given as mean ± s.d. The statistical cal-(2) sixteen patients with normal-renin essential culation was performed using 'Primer' software hypertension (8 men and 8 women; mean age (Primer of Biostatistics S.A. Glantz, McGraw-Hill, 46.5 ± 13.4 years);
San Francisco, CA, USA, 1987). The individual (3) eleven patients with high-renin essential hypervalues were inserted by group on the sheet and were tension (7 men and 4 women; mean age 40.7 ± evaluated using ANOVA followed by Bonferroni's 13.8 years).
t-test, whenever appropriate. Correlation between Twelve healthy subjects (7 men and 5 women;
ET-1 values and other variables were determined by mean age 41.3 ± 11.4 years) were evaluated as a conmeans of linear regression analysis. A P value Ͻ0.05 trol group. Standard clinical and laboratory examinwas considered statistically significant. ations were performed on all subjects.
The diagnosis of essential hypertension was estab-
Results
lished before the study by the absence of any clinical evidence of secondary hypertension: normal serum All participants completed the study. Basal demoelectrolytes, creatinine and normal urinalysis, norgraphic data are shown in Table 1 . The groups were mal abdominal sonogram, normal 12-lead electrowell matched for age and BP levels were significardiogram (ECG) and a normal fundoscopic examcantly different between hypertensive and normotination.
ensive subjects (ANOVA 0.000; P Ͻ 0.05). The mean All patients were free of coronary artery disease, plasma ET-1 levels of the hypertensives was 10.4 ± diabetes mellitus, hyperthyroidism or clinically sig-3.4 pg/ml; there was not a statistical correlation nificant liver disease. No subjects were overweight between PRA and ET-1 levels of the hypertensives (body mass index Ͻ27 kg/m 2 ).
(P Ͼ 0.05); instead there was a statistically signifiAll recruited subjects adhered to a diet of 120-140 cant correlation between plasma endothelin and PA mmol/day of sodium (Na + ) and 40-60 mmol/day of in all hypertensives (r = 0.393; P Ͻ 0.026). potassium (K + ) for at least 2 weeks prior to the testOnly patients with low-renin essential hypertening, and 24-h Na-K urine collection evaluation consion showed mean heart rate values statistically sigfirmed the adherence to the diet. nificantly higher than the normal group (P Ͻ 0.05). On the day of the study the fasted subjects were
Patients with low-renin essential hypertension studied between 08.00 and 09.00 am. A venous canshowed higher PA values than those of healthy subnula was inserted in the antecubital vein in all subjects (Table 1) ; the characteristics of subjects affecjects in the supine position and they remained ted by low-renin hypertension are reported in supine for 60 min before venous blood samples were Table 2 . drawn. Plasma samples were drawn in tubes con- Figure 1 shows the behaviour of plasma ET-1 in taining edetic acid (EDTA) for PRA and PA, and the matched groups. ET-1 mean values of patients EDTA plus aprotine for ET-1, and then immediately with low-renin essential hypertension (12.6 ± 2.1 placed in ice. The samples were centrifuged at 4°C pg/ml) are significantly higher (ANOVA 0.000, P Ͻ and stored −70°C until assayed. 0.05) than those of healthy subjects (7.7 ± 1.7 pg/ml), patients with normal-renin essential hypertension (8.5 ± 2.8 pg/ml), and patients with high-renin Methods essential hypertension (9.9 ± 3.8 pg/ml). No significant difference was found between plasma ET-1 con-PRA was measured in duplicate by methods described by Haber et al 20 using radioimmunoassay centration in hypertensive patients with normal and high-renin essential hypertension ( Table 1 ). The cor-(RIA) kits (Sorin, Saluggia, Italy). The intraassay relation study showed a statistical positive linear concentrations were significantly increased with respect to those of normal subjects and to hypertenregression between PA and plasma ET-1 levels in patients with low-renin essential hypertension (r = sive patient groups. Moreover, we found a positive correlation between plasma ET-1 levels and PA con-0.619; P Ͻ 0.024) (Figure 2) . centrations in patients with low-renin essential hypertension.
Discussion
Our results in normotensive control subjects and in patients with normal-renin essential hyperten-ET-1 a peptide isolated from the media of cultured vascular endothelial cells exerts marked vasomodulsion were almost similar to those reported by previous investigators. 6, 7, 24 atory, with mainly vasoconstrictive effects 1 and may represent a major factor in the regulation of BP. The
The pathophysiological concentration of ET-1 in our patients with low-renin essential hypertension presence in plasma of ET-1 23 raises the possibility that an excess in production of this substance may may be causally related to the development or maintenance of hypertension. Accumulating lines of eviplay a role in the development or maintenance of hypertension.
dence suggest that ET-1 may be involved in the regulation of BP and body fluid homeostasis through its Furthermore, some data suggest that in human essential hypertension plasma ET-1 concentration is paracrine actions on release of other hormones, such as aldosterone 16 and vasopressin. 25 Moreover, both not greatly increased 6, 7 except in the presence of renal failure and/or organ damage. [3] [4] [5] However, the in vitro and in vivo studies suggest that ET-1 can modulate the secretion of renin from juxtaglomerupathophysiology of ET-1 in human hypertension is far from being understood. lar cells of the renal cortex. However, these studies lead to apparently opposite results: in vitro ET-1 The purpose of the present study was to determine the relationship between the renin-angioteninvariably suppresses renin secretion, 13, 14 while injection of ET-1 into animals does not either effect sin-aldosterone system and plasma ET-1 levels in hypertensive patients with low, normal and highor increase PRA. 11, 12, 26 In healthy human volunteers, infusion of 0.4 pmol/kg/min ET-1, which elevated renin essential hypertension. The data that emerged from our study demonstrated that in patients with ir-ET-1 to levels similar to those found in several pathological conditions, increased diastolic BP, low-renin essential hypertension, the plasma ET-1 potentiates the angiotensin II-induced production of aldosterone. 30 It is well known that an increase in the circulating plasma levels of aldosterone produces a sustained salt-dependent increase in arterial pressure.
Therefore, in the current investigation, it is conceivable that in patients with low-renin essential hypertension, increased ET-1 concentration induced elevation in PA levels (with a positive correlation) sufficient to produce hypertension.
In conclusion, the results of this study suggest a role of ET-1 in this particular form of human essential hypertension. Additional studies are required to further describe the potential interaction between the renin-angiotensin-aldosterone system and ET-1 in hypertension.
